Hysbysiad dyfarnu contract
Canlyniadau'r weithdrefn gaffael
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
UNIVERSITY OF CHESTER
PARKGATE ROAD
CHESTER
CH14BJ
UK
Person cyswllt: Procurement Services
Ffôn: +44 1244512395
E-bost: procurement@chester.ac.uk
NUTS: UKD63
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: www.chester.ac.uk
I.4) Y math o awdurdod contractio
Corff a lywodraethir gan gyfraith gyhoeddus
I.5) Prif weithgaredd
Addysg
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
Oxford Medical Simulation (OMS) VR Platform Licenses
Cyfeirnod: 2022-Mar-V-01
II.1.2) Prif god CPV
48100000
II.1.3) Y math o gontract
Cyflenwadau
II.1.4) Disgrifiad byr
The University of Chester has been awarded funding from Health Education England for the OMS VR Platform for 5years. This follows the publishing of Voluntary ex ante transparency notice 2022/S 000-007413.
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Na
II.1.7) Cyfanswm gwerth y caffaeliad
Gwerth heb gynnwys TAW: 416 632.50 GBP
II.2) Disgrifiad
II.2.3) Man cyflawni
Cod NUTS:
UKG
II.2.4) Disgrifiad o’r caffaeliad
The University of Chester has been awarded grant funding from Health Education England ("HEE") for the OMS VR Platform for 5 years. Using the OMS platform clinicians have the opportunity to manage patients in a safe and secure learning environment, learning from their experiences to optimise decision-making, critical thinking and clinical reasoning. This evidence-based approach aligns with NHS policies and procedures to improve the confidence and competence of medical students and practitioners.
Virtual reality (VR) is an emerging technology and, in medical education, is in its infancy. Oxford Medical Simulation (OMS) have created a medical education and training platform that delivers learning using unique, engaging, immersive and interactive methods. It is specifically designed to translate theory to practice to influence patient care.
OMS are named in the HEE grant agreement.
II.2.5) Meini prawf dyfarnu
Price
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Ydy
Disgrifiad o’r opsiynau:
The contract can be extended following the agreement of both parties.
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
II.2.14) Gwybodaeth ychwanegol
The University is contracting with OMS for a 5 year period and published its intention in this regard via a VEAT notice to maximise transparency and to confirm the process to be followed. The University has left over 10 days standstill period between the publishing of the VEAT notice and this award notice.
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Dyfarnu contract heb gyhoeddi galwad am gystadleuaeth yng Nghyfnodolyn Swyddogol yr Undeb Ewropeaidd ymlaen llaw
Cyfiawnhau'r weithdrefn ddyfarnu a ddewiswyd:
Dim ond am y rheswm canlynol y gall gweithredwr economaidd penodol ddarparu'r gwaith, y cyflenwadau neu'r gwasanaethau: diogelu hawliau unigryw, gan gynnwys hawliau eiddo deallusol
Esboniad
Grant funding for this contract has been provided by HEE which has strict conditions with regards
to:
- timelines by which the funding provided has to be spent. This requires full utilisation of the investment by 31st March 2022.
- Compliance with the terms of the grant funding; including sums to be spent with named suppliers.
Any delay in awarding this contract would risk HEE withdrawing funding from University of Chester. Failure to adhere to the grant funding terms would also entail clawback.
Virtual reality is an emerging immersive technology in medical training. OMS has been created by clinicians for clinicians. The platform provides training to healthcare professionals in a unique and interactive way allowing learners to practice and learn from their mistakes in a way that is safe and supported.
The OMS Platform has been trialed by several other HEE regions and is now being adopted more widely as an everyday teaching tool. Additionally, OMS was selected as one of only 12 companies to be part of the NHS Innovation Accelerator in 2021, after undergoing a rigorous evaluation process. This
initiative supports high- impact, evidence-based innovations to scale within the NHS - which provides a further level of evaluation.
Health Education England detailed the Oxford Medical Simulation platform in their grant confirmation of funding letter issued to the University of Chester on 9th March 2022, creating an exclusive right.
As a result, University of Chester believes that Public. Contracts Regulations 2015, Regulation 32(2)applies.
Regulation 32(2) states:
"The negotiated procedures without prior publication may be used for public works contracts, public supply contracts and public service contracts in any of the following cases:-
(b) where the works, supplies or services can be supplied only by a particular economic operator for any of the following reasons:-
(ii) competition is absent for technical reasons,
(iii) the protection of exclusive rights, including intellectual property rights,
(c) insofar as is strictly necessary where, for reasons of extreme urgency brought about by events unforeseeable by the contracting authority, the time limits for the open or restricted
procedures or competitive procedures with negotiation cannot be complied with."
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Ydy
IV.2) Gwybodaeth weinyddol
IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon
Rhif yr hysbysiad yn OJ S:
2022/S 000-007413
Section V: Dyfarnu contract
Rhif Contract: 2022-Mar-V-01
Dyfernir contract/lot:
Ydy
V.2 Dyfarnu contract
V.2.1) Y dyddiad y daeth y contract i ben
30/03/2022
V.2.2) Gwybodaeth am dendrau
Nifer y tendrau a ddaeth i law: 1
Nifer y tendrau a ddaeth i law gan BBaChau: 1
Dyfarnwyd y contract i gr?p o weithredwyr economaidd:
Na
V.2.3) Enw a chyfeiriad y contractwr
Oxford Medical Simulation
201 Borough High Street
London
SE1 1JA
UK
NUTS: UKI
BBaCh yw’r contractwr:
Ydy
V.2.4) Gwybodaeth am werth y contract/lot (heb gynnwys VAT)
Cyfanswm gwerth y contract/lot: 416 632.50 GBP
V.2.5) Gwybodaeth am is-gontractio
Section VI: Gwybodaeth ategol
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
University of Chester
Chester
UK
VI.5) Dyddiad anfon yr hysbysiad hwn
30/03/2022